A detailed history of Fjarde Ap Fonden transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fjarde Ap Fonden holds 53,323 shares of NBIX stock, worth $6.69 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
53,323
Previous 42,023 26.89%
Holding current value
$6.69 Million
Previous $5.8 Million 6.0%
% of portfolio
0.06%
Previous 0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$114.58 - $153.15 $1.29 Million - $1.73 Million
11,300 Added 26.89%
53,323 $6.14 Million
Q1 2024

Apr 25, 2024

BUY
$130.4 - $143.74 $456,400 - $503,090
3,500 Added 9.09%
42,023 $5.8 Million
Q4 2023

Feb 14, 2024

SELL
$106.07 - $132.76 $655,194 - $820,058
-6,177 Reduced 13.82%
38,523 $5.08 Million
Q3 2023

Oct 23, 2023

BUY
$94.02 - $117.1 $733,356 - $913,380
7,800 Added 21.14%
44,700 $5.03 Million
Q2 2023

Aug 02, 2023

BUY
$89.53 - $104.87 $984,830 - $1.15 Million
11,000 Added 42.47%
36,900 $3.48 Million
Q1 2023

May 15, 2023

BUY
$94.11 - $123.02 $385,851 - $504,382
4,100 Added 18.81%
25,900 $2.62 Million
Q4 2022

Feb 14, 2023

SELL
$106.72 - $127.06 $565,616 - $673,418
-5,300 Reduced 19.56%
21,800 $2.6 Million
Q2 2022

Aug 11, 2022

SELL
$75.79 - $100.07 $90,948 - $120,083
-1,200 Reduced 4.24%
27,100 $2.64 Million
Q1 2022

May 13, 2022

SELL
$72.45 - $94.81 $550,620 - $720,556
-7,600 Reduced 21.17%
28,300 $2.65 Million
Q4 2021

Feb 15, 2022

BUY
$79.65 - $106.22 $127,440 - $169,952
1,600 Added 4.66%
35,900 $3.06 Million
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $241,304 - $277,284
-2,800 Reduced 7.55%
34,300 $3.29 Million
Q2 2021

Aug 12, 2021

BUY
$89.43 - $102.27 $187,803 - $214,767
2,100 Added 6.0%
37,100 $3.61 Million
Q1 2021

May 17, 2021

BUY
$87.57 - $119.4 $70,056 - $95,520
800 Added 2.34%
35,000 $3.4 Million
Q4 2020

Feb 12, 2021

BUY
$86.91 - $108.33 $260,730 - $324,990
3,000 Added 9.62%
34,200 $3.28 Million
Q3 2020

Nov 13, 2020

BUY
$96.16 - $135.15 $259,632 - $364,905
2,700 Added 9.47%
31,200 $3 Million
Q2 2020

Aug 13, 2020

SELL
$85.09 - $130.36 $59,563 - $91,252
-700 Reduced 2.4%
28,500 $3.48 Million
Q1 2020

May 11, 2020

SELL
$75.11 - $113.76 $37,555 - $56,880
-500 Reduced 1.68%
29,200 $2.53 Million
Q4 2019

Feb 10, 2020

BUY
$86.8 - $118.57 $2.58 Million - $3.52 Million
29,700 New
29,700 $3.19 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Fjarde Ap Fonden Portfolio

Follow Fjarde Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.